EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.Published in:Journal of Experimental Therapeutics & Oncology, 2005, v. 5, n. 1, p. 69By:Shimizu, Masahito;Deguchi, Atsuko;Joe, Andrew K.;Mckoy, Judith F.;Moriwaki, Hisataka;Weinstein, I. BernardPublication type:Article